Trials / Completed
CompletedNCT04077203
Biofeedback of Glucose in Non-diabetic Participants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Klick Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.
Detailed description
The purpose of this research is to examine whether self-monitoring and biofeedback of glucose levels improves health outcomes in non-diabetic participants. All participants will receive a continuous flash glucose monitor (consisting of an adhesive patch sensor and a handheld reader device) to wear for 14 days. Participants will be randomized into one of 2 groups: those receiving biofeedback (the ability to visualize their glucose levels via the handheld device), and the control group (receiving no biofeedback because the handheld device monitor will be occluded with black tape). Participants' objective and self-report health metrics will be measured before and after the 14-day intervention. The goal is to examine whether the biofeedback condition influences any daily activities or physiological measurements compared to the control condition, as a direct result of self-monitoring glucose levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Biofeedback / No biofeedback | Biofeedback / No biofeedback |
Timeline
- Start date
- 2019-07-16
- Primary completion
- 2019-11-30
- Completion
- 2019-11-30
- First posted
- 2019-09-04
- Last updated
- 2020-11-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04077203. Inclusion in this directory is not an endorsement.